Funder
National Natural Science Foundation of China
Beijing Institute of Technology Research Fund Program for Young Scholars
Fundamental Research Funds for the Central Universities
Hunan Provincial Natural Science Foundation
Hu-Xiang Young Talent Program
Postdoctoral Science Foundation of China
Subject
Biotechnology,Bioengineering,Applied Microbiology and Biotechnology
Reference293 articles.
1. Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy;Adams;BMC Neurol.,2017
2. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis;Adams;N. Engl. J. Med.,2018
3. HBcrAg, HBV-RNA declines in A Phase 2a Study Evaluating the Multi-dose Activity of ARB-1467 in HBeAg-Positive and Negative Virally Suppressed Subjects with Hepatitis B;Agarwal;Hepatology,2017
4. Development of lipidoid-siRNA formulations for systemic delivery to the liver;Akinc;Mol. Ther.,2009
5. Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression;Aleku;Cancer Res.,2008
Cited by
219 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献